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Abstract  
 
Hydatid disease is a frequently encountered entity in endemic areas and constitutes a serious health problem. The lung 
is the second most commonly affected organ after the liver. In three of four cases of pulmonary hydatid cyst, the cyst is 
solitary. The early phase after primary infection is always asymptomatic. Primary symptoms in patients with 
pulmonary cystic echinococcosis include cough, fever, and chest pain. The clinical and radiological manifestations for 
the hydatid cyst in the lung depend on the integrity of the cyst. Bronchial fistulization is an important event in the 
evolution of the cyst. In cases of dubious orientation after the initial study, ultrasonography, conventional tomography, 
and magnetic resonance imaging prove helpful in delineating the disease accurately. For a specific serologic diagnosis, 
the immunoglobulin G enzyme-linked immunosorbent assay and immunoelectrophoresis are preferred. Despite the 
efficacy of new chemotherapeutic regiments, the mainstay of treatment for thoracic hydatidosis remains essentially 
surgical. In general chemotherapy is used as a complement to surgical treatment to avoid recurrence of the disease. 
Regardless of the surgical methods adopted, the removal of the parasite intoto, prevention of its dissemination, 
maximum preservation of pulmonary function, and the immediate obliteration of the remaining cavity are the 
imperative basis for effective therapy. The most frequent post-surgical complications are pleural infection and 
prolonged air leakage. The operative morbidity and recurrence rates have been reported with variation. Education of 
the population in endemic areas regarding the disease transmission cycle and institution of appropriate prophylaxis are 
essential steps to eradicate the disease completely. 
 
 
Keywords: Thoracic hydatidosis; Lungs; Treatment; Diagnosis; Radiology  
 
Introduction 
 
Hydatid disease of the thorax is caused by the cestode 
Echinococcus granulosus. The disease has been 
known since the times of Galen, being described by 
Thebesius in the 17th century [1, 2]. Over the years, 
thoracic echinococcosis has been increasingly recog- 
nized as an important cause of mortality and morbidity 
in susceptible populations. Its wide geographic 
distribution and amenability to primarily surgical 
treatment are important considerations. In this review, 
we discuss the epidemiology, life cycle, clinical and 
radiographic features, laboratory investigations and 
treatment modalities for thoracic hydatidosis. 
 
Epidemiology 
 
Hydatid disease is found worldwide; being frequently 
encountered in endemic areas such as Mediterranean 
countries, New Zealand, Australia, North America, 
South America, Central America, and Asia [2]. The 
distribution of Echinococcus granulosus is influenced 
by agricultural, economic, and educational levels, and 
cultural habits [3]. For the developing world, this has 
important implications because rural inhabitants in 
these areas live under poor sanitary conditions [2]. 
The annual incidence of the disease ranges from less 
than 1 to 220 per 100,000 inhabitants of various 
endemic areas [3].  
 
Life Cycle of Echinococcus granulosus 
 
The life cycle of the tapeworm includes synanthropic 
and sylvatic cycles. Humans act as accidental inter- 
mediate hosts for the Echinococcus granulosus. The 
adult tapeworm stage is harbored in the small intestine 
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of a carnivore, (e.g. dogs, coyotes and wol- ves) called 
the definitive host. The tapeworm eggs are passed in 
the feces of infected carnivore and are ingested by 
herbivores (e.g. sheep, cattle and goats) called the 
intermediate host. The eggs hatch in the intestine of 
the herbivore, penetrate the mucosal wall and reach 
the liver via the portal circulation, where they develop 
into hydatid cysts. Sometimes, they pass through the 
liver barrier and reach the lungs and virtually any 
other organ of the body. Humans are affected if they 
ingest food or water contaminated with feces of 
definitive host containing the eggs of Echinococcus 
granulosus [2, 4]. Figure 1 shows the life cycle of 
Echinococcus granulosus.  
 
Thoracic Hydatid Cyst Disease 
 
The lung is the second most commonly affected organ 
after the liver [5]; being infected in 10-40% of the 
cases [6]. The hydatid cyst can develop anywhere in 
the lung, but it settles more often on the right side and 
has a predilection for the lower lobe [6-8]. Its size can 
range from a few centimeters to giant hydatid cysts 
that can occupy the whole hemithorax [9]. There is no 
universally accepted size to define a pulmonary 
hydatid cyst as “giant”; however, 10 centimeters 
seems an appropriate length in that it equals nearly 
half of the hemithorax of most patients [10, 11].  
 
In three of four cases, the cyst is solitary. Multiple 
cysts (either primary or secondary) can be unilateral or 
bilateral. Ayetac et al. reported that 72% of their cases 
had single cysts, 15% had multiple unilateral cysts, 
and 13% had multiple bilateral cysts [12].  
 
Factors Affecting Growth of Hydatid Cyst 
 
The growth rate of the parasite changes with the 
degree of host sensitization and tissue influences [10]. 
In the liver, the compact tissue and the hepatobiliary 
capsules limit the cysts growth but the low resistance 
of the lung provides an excellent medium for rapid 
growth of hydatid cysts. The patient’s immune respo- 
nse to the parasite and early symptoms during the 
illness prevent the cyst from growing in an unlimited 
fashion [10].  
 
Clinical Features of Thoracic Hydatid Cyst Disease 
 
The early phase after primary infection is almost 
always asymptomatic. Depending on the size and site 
of the developing hydatid cyst, the infection can 
remain asymptomatic for months, years, or even 
longer. In the general population, the overall preva- 
lence of asymptomatic cysts in the liver (2.5%) was 
found to be much higher than that of cysts in the lung 
(0.3%), giving a ratio of liver infection: lung infection 
of 8.3:1. In the symptomatic cases, however, the ratio 
was only 2.5:1 (based on hospital records) or 
4.1:1(based on autopsy records) [13].  
After a highly variable incubation period, the 
infestation may become symptomatic because of a 
range of different events. For example, pressure 
effects of the growing cyst cause cough, hemoptysis, 
pneumothorax and pleuritis.  Rupture with spillage of 
the contents of the cyst leads to hypersensitivity 
reactions such as anaphylaxis. Superinfection of the 
cyst causes signs and symptoms of infection and is an 
urgent indication for surgical intervention [14, 15].   
   Irrespective of the organ affected, most patients 
with cystic ecchinococcosis, have single organ 
involvement with solitary cysts. Simultaneous invol- 
vement of two or more organs is observed in 10% to 
15% of patients, depending on the geographic origin 
of the patient and the strain of the parasite, 
respectively. Approximately, 10% of hepatic cystic 
ecchinococcosis cases occur in children, whereas the 
rate of lung infection is significantly increased among 
this group of young patients and may reach 50% [16].  
 
Imaging the Hydatid Cyst 
 
Before bronchial rupture, the typical image of a simple 
cyst (intact, close, hyaline) is that of a homogenous 
opacity, round with definite edges, situated in the 
pulmonary field itself, or apparently implanted on the 
liver, heart, or rachis [17]. The entrance of air between 
hydatid cyst and adventitia through bronchiopericystic 
fistula allows a perivesicular pneumocyst, air 
meniscus, or crescent sign.  
At the time of bronchial rupture, the radiological 
examination often shows an important parenchy- 
matous reaction, not only homolaterally but also 
contralaterally. There is a diffuse dense opacity on the 
cyst’s side; on the opposite sides the opacities are less 
dense, less homogenous, and less limited, which is 
related to pulmonary hydatid anaphylaxis. It disapp- 
ears in 4 to 5 days, revealing the original cystic image 
with its modifications. After the bronchial rupture, the 
images are highly varied. The parasitic membrane, 
partially detached from adventitia, creates a bridge 
over the fluid: Ivanissevich’s double arch’s sign or 
Jaubertand Brun’s double outline (two superposed 
gaseous areas, one intracystic and other intraadv- 
entitial, separated by parasitic membrane) [17]. The 
cystic membrane drops, floating on the surface of the 
residual fluid and giving the Belot’s sign of floating 
membrane or Lagos Garcia and Segars’ sign of the 
water lily or camalote. A cyst that perforates into the 
pleural cavity can appear with radiological signs of a 
hydrothorax or a hydropneumothorax. With multiple 
primary ecchinococcosis, radiology reveals cysts of 
different sizes and configurations in one or both lungs. 
With bronchogenic secondary ecchinococcosis, the 
cysts are normally bilateral. Secondary metastatic 
ecchinococcosis manifests as numerous small round 
opacities that are bilateral and generally symmetric.  
 
Other Imaging Modalities 
 
 In cases of dubious orientation after the initial study, 
the data facilitated by ultrasonography, conventional 
tomography, and magnetic resonance imaging are 
most interesting [18]. These methods can reveal 
certain details of the lesions and discover others that 
are not visible by conventional radiography.  CT scan 
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can also visualize signs of onset of complications, 
such as incipient membrane detachment of small 
bubbles located in the cyst wall [18]. MRI allows 
reliable differentiation because the cyst has low signal 
intensity on T-1 weighted images and high signal 
intensity on T-2 weighted images [14]. For pulmonary 
sites, ultrasound examination is unhelpful in most 
cases, but sometimes it can confirm the cystic nature 
of the parenchymatous mass that is juxtaparietal [19]. 
Hepatic ultrasound should be used routinely for 
diagnosis of associated hepatic involvement as the two 
entities can coexist. 
 
Laboratory Diagnosis of Hydatid Cyst Disease 
 
If aspiration cytology is performed, trichromic 
staining of the filtrated aspirate reveals acid fast 
hooklets [20]. Cytology seems particularly helpful in 
detecting pulmonary involvement [21]. Viability of 
aspirated protoscolices can be determined by 
microscopic demonstration of flame cell activity and 
Trypan Blue dye exclusion. Laboratory diagnosis of 
cystic hydatid disease is complementary to the clinical 
data [22]. For closed cysts whose membrane begins to 
exfoliate or open ones where the cuticular layer has 
been fragmented, the true diagnosis is occasionally 
provided by the microscopic discovery of cuticular 
remnants or hooklets in expectorated material. The 
eosinophilia and precocious positivity of Casoni’s 
intradermal reaction were at one time helpful 
elements, despite their variable sensitivity and limited 
specificity [23-25].  
In the most recent experience, the most sensitive 
technique was the specific immunoglobulin G (IgG) 
ELISA test [26]. However, for pulmonary cyst 
localization, the diagnostic sensitivity is lower than 
that of hepatic cases. These tests are generally used for 
primary serological screening. Specificity of such tests 
increases considerably when using , for example, the 
antigen 5- precipitation test (arc 5 test) or 
immunoblotting for a relatively specific 8kD/12kD 
hydatid fluid polypeptide antigen [27, 28]. The 
demonstration of parasite specific IgE has attracted 
particular attention because of its well known 
relevance in helminthic diseases [29, 30] but has 
exhibited no significant immunodiagnostic advantage 
in cystic ecchinococcosis. There are also problems of 
diagnostic sensitivity and specificity because of cross 
reactions related not only to infections with 
heterologous helminthic species but also to 
malignancies [31, 32] and the presence of anti P1- 
antibodies [33].  
Monoclonal antibodies (MAbs) generated against 
different parasite antigens have been used for the 
diagnosis of cystic echinococccosis by detection of 
circulating antigens in patients’ sera or of native 
proteins in biopsies. Such MAbs have been directed 
mainly against 2 major E. granulosus antigens: antigen 
5 and antigen B [34]. The serological tests are also 
useful for the postoperative follow up. The antibody 
production rate shows an elevation during the first 4 to 
6 weeks after the operation followed by a drop, more 
or less abrupt, during the 12 to 18 subsequent months. 
In patients with recurrence before 2 years, antibody 
production remains at a level similar to that seen 
preoperatively [26].  
 
Treatment of Thoracic Hydatidosis 
 
Every pulmonary hydatid cyst that is identified must 
be treated.  
 
1. Medical Treatment  
 
The treatment is essentially surgical, despite the 
efficacy of new chemotherapeutic regimens advocated 
by some quarters [35]. Dogan et al. noted that after 
applying mebendazole 4 of 28 patients had to undergo 
urgent operation owing to massive hemoptysis [36]. In 
general chemotherapy is used as a complement to 
surgical treatment to avoid recurrence. It is applied 
preoperatively to prevent the consequences of possible 
rupture of the cysts during surgery and postoperatively 
as adjuvant therapy of the cysts that ruptured during 
the operation. It is also suitable for patients with 
multiple cysts, where in vitro studies of the parasite 
show high fertility and viability and patients who 
cannot undergo surgery [37]. Two benzimidazole 
compounds (mebendazole and albendazole) and prazi- 
quantel have activity against Echinococcus granulosus 
in vitro and in animal models [38, 39]. No controlled 
studies have ever been performed in humans so far. 
Albendazole seems preferable to mebendazole beca- 
use of its better bioavailability. [40, 41] Both drugs 
penetrate into the cysts [42, 43], but sometimes heroic 
doses are needed to achieve a therapeutic plasma 
concentration of mebendazole [44]. The generally 
accepted therapeutic levels are approximately 250 
nmol/L. The former use of albendazole in cycles of 4 
weeks, followed by a drug-free interval of 2 weeks, 
has been replaced more frequently with a continuous 
treatment [45, 46]. In a small comparative study, all 
six patients on continuous therapy showed cyst 
involution, whereas relapse occurred in the cycling 
group [47].   
 
 
2. Surgical Treatment 
 
Because there is great variability in the pathology 
among pulmonary hydatid cysts, a uniform treatment 
cannot be recommended. However, there are two 
objectives: 
1.   To remove the parasite; and 
2.  To treat bronchio-pericystic pathology and other 
associated lesions. 
Therefore, modern surgical treatment must be 
individualized for each case. Regardless of the 
surgical methods adopted, the removal of the entire 
parasite, prevention of its dissemination, maximum 
preservation of pulmonary function, and the imme- 
diate obliteration of the remaining cavity are the basis 
for effective therapy. 
In most cases in intact cysts, simple removal fulfills 
all these requirements and certainly is the ideal 
approach. The  host  membrane  is widely opened by a  
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Figure 1. Schematic life cycle of Echinococcus granulosus (Redrawn from F.L Andersen, A.G. Barbour, F.J. 
Schoenfeld, Proceedings of 78th Meeting of United States Animal Health Association 78:370, 1974) 
 
 
short incision that surrounds the most superficial part 
of the cyst in the visceral pleura. Until hemostasis is 
secured, the enucleation method, originally described 
by Ugon [48] and Barret [49], is the most adequate 
technique to remove intact small and medium 
pulmonary cysts. Peschiera [50] suggested that the 
live contents should initially be evacuated to prevent 
the risk of contamination by rupture of the cyst during 
removal. During evacuation of the contents of large 
cysts, a scolicidal solution is used to avoid 
contamination of operative field. Formaldehyde 
solution or pure formaldehyde has been suggested by 
many authors, but leakage of these substances is 
harmful to the pericystic tissues and therefore 
interferes with the healing process and increases the 
incidence of bronchopleural fistula [51]. The use of 
hypertonic saline is less harmful to the tissues and is 
recommended by many surgeons [52].  
After the removal of the cyst, the remaining cavity can 
be treated in a variety of ways. In 1948, Perez-Fontana 
[53] from Uruguay suggested the resection of host 
membrane, pericyst, with the intact cyst, as routine to 
prevent infectious complications that result from 
residual cavities with walls that are too thick to 
collapse spontaneously. The resection of the host 
membrane identifies bronchial leaks into the parasitic 
chamber. They are sutured, and then the cyst is closed 
with a spiral suture that approximates the walls 
surrounding the wound left in the pulmonary 
parenchyma caused by the removal of the cyst and its 
adventitia. In Perez-Fontana pericystectomy [53], 
there is more bleeding and air leakage.  
Regarding the management of cystic cavity in 
complicated or intact cysts, Delbet [54] first described 
the method called capitonnage, which is the folding of 
the pericystic zones by sutures. Crausaz [55] reported 
that purse-string sutures from the base of the pericyst 
cavity upward could be used to obliterate the cavity.  
 
 
It is generally agreed, however, that the most 
important point in the management of the residual 
pericystic cavity is closure of patent bronchial 
openings. Saidi [51] pointed out that approximating 
and suturing cavity edges is not necessary because the 
pulmonary parenchyma obliterates the space, and the 
surface of the lung at the site of residual cavity is 
covered by pleura.  
If intraoperative pleural contamination occurs, 
flooding the cavity with scolicidal agents is 
worthwhile. Hypotonic (distilled water) or hypertonic 
(10% saline) solutions, or 10% formaldehyde solution 
may be employed. The potential complications 
associated with spillage of hydatid cysts include 
anaphylactic shock, pleural contamination with 
resulting secondary hydatidosis, and contralateral 
bronchial dissemination. The routine use of double-
lumen endotracheal tubes or bronchial blockers avoid, 
during manipulation of the effected lung, hydatid 
material going into the bronchial tree [56].  
 
3. Role of PAIR In Thoracic Hydatidosis 
 
Puncture, aspiration, injection of a helminthicide, and 
reaspiration (PAIR) have been propagated for hepatic 
forms of hydatidosis. A meta-analysis comparing 
clinical outcomes for hepatic cystic echinococcosis 
found that the rate of clinical and parasitologic cure 
(p=<0.0001) was greater in patients receiving 
percutaneous aspiration-injection-reaspiration (PAIR) 
plus chemotherapy (albendazole or mebendazole) as 
compared to patients receiving surgical intervention. 
However, this form of therapy was associated with a 
higher rate of fever and minor allergic reactions as 
compared to surgical intervention [57]. For pulmonary 
hydatidosis, this technique is generally not indicated 
[45].  
 
 
Eggs hatch, penetrate the  
bowel wall and form hydatid  
cysts in various body  
organs of herbivores 
 
Eggs of parasite passed 
 in feces of carnivore 
Accidental ingestion 
of parasite eggs 
by humans 
Definitive carnivore  
hosts eat body organs of
Infected herbivores  
 
Adult tapeworm in small
intestine of carnivore 
Intermediate herbivore 
hosts ingest the eggs 
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Results of Treatment 
 
The operative morbidity has been variably reported in 
different studies. [10, 25, 58] The most common 
complications are pleural infection and prolonged air 
leakage; seen in 2.54% and 2.19% cases respectively. 
[23] Operative mortality, in general, today does not 
exceed 1% to 2%. The nature of intervention is a less 
important factor than the general condition of the 
patient, the characteristics of the cyst(s), the degree of 
repercussion on the remaining parenchyma, and the 
associated lesions. 
 
Recurrence of Disease 
 
The recurrence rate is also variable; commonly 
ranging between 1.5% to 2.5% [59]. Chevret et al. 
[60] reported a series of 1397 pulmonary hydatid 
cysts, with 7 early recurrences successfully operated 
on and 34 late recurrences with a more than 3-year 
disease-free interval. The early recurrences were 
attributed to a lack of knowledge of incipient 
microcysts and the later ones to re-infestations. The 
authors thought that removal of the whole cyst, an 
excellent intervention surgically speaking, did not 
allow specific immunity to develop, so the individual 
was prone to re-infestation. In 14 patients, the 
recurrence was literally explosive from a true 
confluence of bilateral cysts, leading to death from 
respiratory failure. 
It remains unclear how to proceed in case of 
asymptomatic patients detected at screening or with 
imaging for unrelated medical problems. In one small 
series of 28 patients followed for more than 10 years, 
75% of patients remained free of symptoms [61].  
 
Conclusions 
 
Despite the low mortality and limited recurrence rate, 
thoracic hydatid disease imposes an important disease 
burden in endemic areas. Some of the complications 
of the disease can be potentially devastating. 
Prophylaxis is therefore warranted. [6] Measures for 
preventing hydatidosis, theoretically easy to 
formulate, are regretfully difficult to apply, especially 
in countries with a high hydatid prevalence rate. This 
is most likely due to a lack on awareness of the 
disease in the populace. The sources of infestation 
must be suppressed or sterilized, and the chain of 
transmission of the parasite must be interrupted. The 
population must therefore be widely informed through 
carefully tailored campaigns.    
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